Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Colinz Laboratories Ltd

NSE: COLINZ · BSE: 531210 · Pharmaceuticals & Biotechnology · 24 announcements

Share price
₹70.00
Market cap
₹17.63 Cr
Revenue (annual)
₹6.14 Cr
Net profit (annual)
₹0.51 Cr
P/E (TTM)
6.3×Sector 47.3×
Promoter holding
50.60%-15.40% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:26 IST BSE
Annual Report

Colinz Laboratories Annual Report

Colinz Laboratories Limited has submitted its 40th Annual Report for the financial year 2025-26. The report includes notice for the Annual General Meeting scheduled for September 22, 2026.